CLINICAL_TRIALS
trial_result
· 2022-05-19
Clinical Trial Update: Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy [Phase 2]
Summary
Phase 2 trial evaluating dupilumab monotherapy in pediatric patients with peanut allergy has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED | Results posted: 2022-05-19